EMA Panel Backs Revoking Authorization of Ulipristal for Fibroids EMA Panel Backs Revoking Authorization of Ulipristal for Fibroids

A PRAC review confirms that ulipristal acetate for uterine fibroids can cause liver injury, including the need for a liver transplant.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news